亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Therapeutic Hydrogels of Nonsteroidal Anti-Inflammatory Drugs

总结
· Oligopeptidescomprising D-amino acids to replace L-amino, produce protease resistant motifs
技术优势
Bio stableand biocompatible supramolecular hydrogels of D-peptides and therapeutic smallmolecules increase target selectivity and decrease adverse drug reactionsTheinvention confers proteolytic resistance and preserves drug activity forsustained releaseAdministered as topical gels or creams to use for relieving pain induced bylocal inflammationThetherapeutic hydrogels serve as a cheap, safe, and effective carrier for drug toreduce ADRsThesynthetic route for said peptidic conjugate is facile, well established, andeasy to scale up
详细技术说明
Therapeutic Hydrogels of Nonsteroidal Anti-Inflammatory Drugs:D-peptides/NSAIDs conjugates boost drugselectivity and reduce side effects
*Abstract

Background:  

Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely andsystematically used in high doses for the treatment of acute or chronic painsand inflammations. NSAIDs effectively relieve pain and treat inflammation bybinding to the cyclooxygenase-2 (COX-2) enzyme. However, NSAIDs also inhibitCOX-1, which causes adverse drug effects (ADRs) such as: gastrointestinal ulceration,stomach bleeding, renal failure, and cardiovascular risks. ADRs not only limitthe use of otherwise effective drugs, but also lead to the attrition of newdrugs in clinical trials.

Until now, nosimple and general approach for reducing “off-target” effects of NSAIDs hasexisted. This invention employs novel multifunctional supramolecularhydrogelators made of unnatural amino acids or peptides (D-amino acids orD-peptides) and an NSAID as a new approach for delivering therapeutic agents bybiostable, target specific, and potent hydrogels. These therapeutic hydrogelsare stable scaffolds for long-term drug release and significantly reduce ADRs,boosting the selectivity for COX-2 over COX-1 by more than 20 times. Thesecompounds may be functionalized with other active agents, such as anticancertherapeutic agents, anti-HIV drugs or imaging agents, therefore fulfillingmultiple biomedicinal roles.


*IP Issue Date
None
*IP Type
Utility
国家
United States
申请号码
14/441,773
国家/地区
美国

欲了解更多信息,请点击 这里
移动设备